Arendsen, G.W., & Aderveen, Hein. (1963) Treatment of the Neurotic Patient, Resistant to the Usual Techniques of Psychotherapy, with Special Reference to LSD. Topical Problems of Psychotherapy. 4, 50-57
Bresloff, P.C., Cowan, J.D., Golubitsky, M., Thomas, P.J, & Wiener, M.C. (2008) What geometric visual hallucinations tell us about the Visual Cortex. Department of Mathematics, University of Chicago. (To appear in Neural Computation)
Daly, J.W., Caceres, J., Moni, R.W., Gusovsky, F., Moos, M.Jr., Seamon, K.B., Milton, K., & Myers, C.W. (1992) Frog secretions and hunting magic in the upper Amazon: Identification of a peptide that interacts with an adenosine receptor. Pharmacology. 89, 10960-10963
Fantegrossi, W.E., Murnane, K.S., & Reissig, C.J. (2008) The Behavioral Pharmacology of Hallucinogens. Biochemical Pharmacology. 75, 17-33
Forsling, M.L., Fallon, J.K., Shah, D., Tilbrook, G.S., Cowan, D.A., Kicman, A.T., & Hutt, A.J. (2002) The effect of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus. British Journal of Pharmacology. 135, 649-656
Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Daumann, J., Obradovic, M., & Kovar, K. (2006) Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis. Neuropsychopharmacology. 31, 431-441
Gresch, P.J., Smith, R.L., Barrett, R.J., & Sanders-Bush, E. (2005) Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex. Neuropsychopharmacology. 30, 1693-1702
Grinspoon, L., M.D., & Bakalar, J.B. (1986) Can Drugs Be Used to Enhance the Psychotherapeutic Process? American Journal of Psychotherapy. 40(3)
Hayman, M.D. (1964) Science, Mysticism, and Psychopharmacology. California Medical Journal. 101(4), 266-271
Jerome, L. (2007) Psilocybin, Investigator's Brochure. MAPS Review.
Lincoff, G. (2005) Is the Fly-Agaric (Amanita Muscaria) an Effective Medicinal Mushroom? Third International Medicinal Mushroom Conference. Port Townsend, WA.
Persinger, M.A., Ph.D., C.Psych. (2001) The Neuropsychiatry of Paranormal Experiences. Neuropsychiatry and Clinical Neuroscience. 13(4), 515-524
Smythies, Ph.D., & Beaton. (1971) Wanted: A Fast Trip Back from LSD. Medical World News. 12(34), 37-38
Vortherms, T.A., & Roth, B.L. (2006) Salvinorin A: From Natural Product to Human Therapeutics. Molecular Interventions. 6(5) 257-265
Walsh, R., M.D. (1983) Psychedelics and Self-Actualization. Human Sciences Press.